{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T23:38:29Z","timestamp":1790293109834,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T00:00:00Z","timestamp":1711324800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016015","name":"University Hospital Basel","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016015","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002329","name":"Federal Office of Public Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002329","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography B"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.jchromb.2024.124104","type":"journal-article","created":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T17:30:26Z","timestamp":1711387826000},"page":"124104","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Development and validation of an LC-MS\/MS method for quantifying diamorphine and its major metabolites 6-monoacetylmorphine, morphine, morphine-3-glucuronide, and morphine-6-glucuronide in human plasma"],"prefix":"10.1016","volume":"1237","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3820-2671","authenticated-orcid":false,"given":"Jan","family":"Thomann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Severin B.","family":"Vogt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Guessoum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Vogel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias E.","family":"Liechti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dino","family":"Luethi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urs","family":"Duthaler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jchromb.2024.124104_b0005","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/01.ftd.0000211812.27558.6e","article-title":"Toxicokinetics of drugs of abuse: current knowledge of the isoenzymes involved in the human metabolism of tetrahydrocannabinol, cocaine, heroin, morphine, and codeine","volume":"28","author":"Maurer","year":"2006","journal-title":"Ther. Drug Monit."},{"issue":"1","key":"10.1016\/j.jchromb.2024.124104_b0010","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2174\/157488406775268219","article-title":"Pharmacokinetics and pharmacokinetic variability of heroin and its metabolites: review of the literature","volume":"1","author":"Rook","year":"2006","journal-title":"Curr. Clin. Pharmacol."},{"issue":"7","key":"10.1016\/j.jchromb.2024.124104_b0015","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/jat\/33.7.345","article-title":"Determination of heroin and its main metabolites in small sample volumes of whole blood and brain tissue by reversed-phase liquid chromatography-tandem mass spectrometry","volume":"33","author":"Karinen","year":"2009","journal-title":"J. Anal. Toxicol."},{"issue":"4","key":"10.1016\/j.jchromb.2024.124104_b0020","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1093\/jat\/21.4.268","article-title":"Simultaneous determination of heroin 6-monoacetylmorphine, morphine, and its glucuronides by liquid chromatography\u2013atmospheric pressure ionspray-mass spectrometry","volume":"21","author":"Zuccaro","year":"1997","journal-title":"J. Anal. Toxicol."},{"issue":"3","key":"10.1016\/j.jchromb.2024.124104_b0025","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1067\/mcp.2001.117981","article-title":"Arterial and venous pharmacokinetics of intravenous heroin in subjects who are addicted to narcotics","volume":"70","author":"Rentsch","year":"2001","journal-title":"Clin. Pharmacol. Ther."},{"issue":"1\u20132","key":"10.1016\/j.jchromb.2024.124104_b0030","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0021-9673(99)00750-5","article-title":"Method for quantification of morphine and its 3-and 6-glucuronides, codeine, codeine glucuronide and 6-monoacetylmorphine in human blood by liquid chromatography\u2013electrospray mass spectrometry for routine analysis in forensic toxicology","volume":"854","author":"Dienes-Nagy","year":"1999","journal-title":"J. Chromatogr. A"},{"issue":"7","key":"10.1016\/j.jchromb.2024.124104_b0035","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0025-6196(11)60750-7","article-title":"Opioid metabolism","volume":"84","author":"Smith","year":"2009","journal-title":"Mayo Clin. Proc."},{"issue":"1","key":"10.1016\/j.jchromb.2024.124104_b0040","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12954-023-00731-y","article-title":"Safety and feasibility of intranasal heroin-assisted treatment: 4-week preliminary findings from a swiss multicentre observational study","volume":"20","author":"Vogel","year":"2023","journal-title":"Harm Reduct. J."},{"issue":"6","key":"10.1016\/j.jchromb.2024.124104_b0045","doi-asserted-by":"crossref","first-page":"501","DOI":"10.2165\/00003088-200342060-00001","article-title":"Intranasal diamorphine as an alternative to intramuscular morphine: pharmacokinetic and pharmacodynamic aspects","volume":"42","author":"Kendall","year":"2003","journal-title":"Clin. Pharmacokinet."},{"issue":"1","key":"10.1016\/j.jchromb.2024.124104_b0050","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/add.14442","article-title":"One size does not fit all-evolution of opioid agonist treatments in a naturalistic setting over 23 years","volume":"114","author":"Nordt","year":"2019","journal-title":"Addiction"},{"key":"10.1016\/j.jchromb.2024.124104_b0055","unstructured":"World Health Organization, Guidelines for Psychosocially Assisted Pharmacological Treatment of Opiate Dependence. https:\/\/iris.who.int\/bitstream\/handle\/10665\/43948\/9789241547543_eng.pdf?sequence=1, 2009 (accessed 21.02.2024.)."},{"issue":"1","key":"10.1016\/j.jchromb.2024.124104_b0060","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1192\/bjp.bp.114.149195","article-title":"Heroin on trial: systematic review and meta-analysis of randomised trials of diamorphine-prescribing as treatment for refractory heroin addiction","volume":"207","author":"Strang","year":"2015","journal-title":"Br. J. Psychiatry"},{"issue":"11","key":"10.1016\/j.jchromb.2024.124104_b0065","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.drugpo.2015.04.009","article-title":"Fire in the vein: heroin acidity and its proximal effect on users' health","volume":"26","author":"Ciccarone","year":"2015","journal-title":"Int. J. Drug Policy"},{"issue":"2","key":"10.1016\/j.jchromb.2024.124104_b0070","first-page":"57","article-title":"Injektionen in die leistenvene: pr\u00e4valenz und umgang in heroingest\u00fctzter behandlung","volume":"17","author":"Vogel","year":"2015","journal-title":"Suchtmedizin"},{"key":"10.1016\/j.jchromb.2024.124104_b0075","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.drugpo.2015.11.003","article-title":"Not in the vein:\u2018missed hits\u2019, subcutaneous and intramuscular injections and associated harms among people who inject psychoactive drugs in Bristol, United Kingdom","volume":"28","author":"Hope","year":"2016","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.jchromb.2024.124104_b0080","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.drugalcdep.2016.11.029","article-title":"A systematic review of injecting-related injury and disease among people who inject drugs","volume":"171","author":"Larney","year":"2017","journal-title":"Drug Alcohol Depend."},{"issue":"1","key":"10.1016\/j.jchromb.2024.124104_b0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12954-021-00584-3","article-title":"\u00abOne prick and then it\u0301 s done\u00bb: a mixed-methods exploratory study on intramuscular injection in heroin-assisted treatment","volume":"18","author":"Meyer","year":"2021","journal-title":"Harm Reduct. J."},{"issue":"1","key":"10.1016\/j.jchromb.2024.124104_b0090","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s13244-020-00903-5","article-title":"The needle and the damage done: musculoskeletal and vascular complications associated with injected drug use","volume":"11","author":"Delaney","year":"2020","journal-title":"Insights Imaging"},{"issue":"2","key":"10.1016\/j.jchromb.2024.124104_b0095","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3109\/00952991003592311","article-title":"Risk practices associated with bacterial infections among injection drug users in Denver","volume":"36","author":"Phillips","year":"2010","journal-title":"Colorado, Am J Drug Alcohol Abuse"},{"issue":"12","key":"10.1016\/j.jchromb.2024.124104_b0100","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1080\/10826084.2016.1188951","article-title":"Internalized stigma among people who inject drugs","volume":"51","author":"Cama","year":"2016","journal-title":"Subst. Use Misuse"},{"key":"10.1016\/j.jchromb.2024.124104_b0105","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.drugalcdep.2019.01.037","article-title":"Strategies used by people who inject drugs to avoid stigma in healthcare settings","volume":"198","author":"Biancarelli","year":"2019","journal-title":"Drug Alcohol Depend."},{"issue":"1","key":"10.1016\/j.jchromb.2024.124104_b0110","first-page":"22","article-title":"Comparison of the detection windows of heroin metabolites in human urine using online SPE and LC\u2013MS\/MS: importance of morphine-3-glucuronide","volume":"44","author":"Wang","year":"2020","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.jchromb.2024.124104_b0115","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jpba.2015.04.044","volume":"114","author":"Moreno-Vicente","year":"2015","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"3","key":"10.1016\/j.jchromb.2024.124104_b0120","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/jat\/bkaa157","article-title":"Heroin-related compounds and metabolic ratios in postmortem samples using LC-MS-MS","volume":"45","author":"Jakobsson","year":"2021","journal-title":"J. Anal. Toxicol."},{"issue":"5","key":"10.1016\/j.jchromb.2024.124104_b0125","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1093\/jat\/bkw022","article-title":"LC-MS-MS method for analysis of opiates in wastewater during football games II","volume":"40","author":"Gul","year":"2016","journal-title":"J. Anal. Toxicol."},{"issue":"1\u20132","key":"10.1016\/j.jchromb.2024.124104_b0130","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jchromb.2005.05.048","article-title":"The quantitative analysis of heroin, methadone and their metabolites and the simultaneous detection of cocaine, acetylcodeine and their metabolites in human plasma by high-performance liquid chromatography coupled with tandem mass spectrometry","volume":"824","author":"Rook","year":"2005","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jchromb.2024.124104_b0135","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jpba.2012.10.033","article-title":"Stability of heroin, 6-monoacetylmorphine, and morphine in biological samples and validation of an LC-MS assay for delayed analyses of pharmacokinetic samples in rats","volume":"74","author":"Jones","year":"2013","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2024.124104_b0140","unstructured":"United States Food and Drug Administration (FDA), Bioanalytical Method Validation Guidance for Industry. https:\/\/www.fda.gov\/files\/drugs\/published\/Bioanalytical-Method-Validation-Guidance-for-Industry.pdf, 2018 (accessed 10.10.2023.)."},{"issue":"1","key":"10.1016\/j.jchromb.2024.124104_b0145","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13722-023-00367-0","article-title":"Feasibility, safety, and acceptability of intranasal heroin-assisted treatment in Switzerland: protocol for a prospective multicentre observational cohort study","volume":"18","author":"Westenberg","year":"2023","journal-title":"Addict. Sci. Clin. Pract."},{"key":"10.1016\/j.jchromb.2024.124104_b0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2020.122486","article-title":"Development and validation of an LC-MS\/MS method for the bioanalysis of psilocybin's main metabolites, psilocin and 4-hydroxyindole-3-acetic acid, in human plasma","volume":"1164","author":"Kolaczynska","year":"2021","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jchromb.2024.124104_b0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2022.114980","article-title":"Development and validation of an LC-MS\/MS method for the quantification of mescaline and major metabolites in human plasma","volume":"220","author":"Thomann","year":"2022","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2024.124104_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2022.123534","article-title":"Liquid chromatography-tandem mass spectrometry method for the bioanalysis of N, N-dimethyltryptamine (DMT) and its metabolites DMT-N-oxide and indole-3-acetic acid in human plasma","volume":"1213","author":"Luethi","year":"2022","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jchromb.2024.124104_b0165","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jchromb.2013.06.030","article-title":"Liquid chromatography-tandem mass spectrometry assay for the EGFR inhibitor pelitinib in plasma","volume":"934","author":"Luethi","year":"2013","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"issue":"10","key":"10.1016\/j.jchromb.2024.124104_b0170","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1002\/bmc.3176","article-title":"Liquid chromatography\u2013tandem mass spectrometric assay for the multikinase inhibitor regorafenib in plasma","volume":"28","author":"Luethi","year":"2014","journal-title":"Biomed. Chromatogr."},{"issue":"7","key":"10.1016\/j.jchromb.2024.124104_b0175","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/j.2042-7158.1992.tb05474.x","article-title":"The effect of temperature and pH on the deacetylation of diamorphine in aqueous solution and in human plasma","volume":"44","author":"Barrett","year":"1992","journal-title":"J. Pharm. Pharmacol."}],"container-title":["Journal of Chromatography B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023224001120?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023224001120?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,9]],"date-time":"2024-04-09T19:19:52Z","timestamp":1712690392000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570023224001120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":35,"alternative-id":["S1570023224001120"],"URL":"https:\/\/doi.org\/10.1016\/j.jchromb.2024.124104","relation":{},"ISSN":["1570-0232"],"issn-type":[{"value":"1570-0232","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and validation of an LC-MS\/MS method for quantifying diamorphine and its major metabolites 6-monoacetylmorphine, morphine, morphine-3-glucuronide, and morphine-6-glucuronide in human plasma","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchromb.2024.124104","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"124104"}}